Genzyme, BioMarin up on PDUFA date

GENZ was up $0.57 to $32.97 and BioMarin (BMRN; SWX:BMRN) was up $0.30 to $9.05 on Tuesday - the PDUFA deadline for FDA action on the companies' BLA for Aldurazyme to treat mucopolysaccharidosis I (MP...